A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction

Circulation

Volumn 94, Issue 4, 1996, Pages 708-712

  Samani, Nilesh J ^a,c   Thompson, John R ^a   O'Toole, Laurence ^b   Channer, Kevin ^b   Woods, Kent L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

angiotensin; enzymes; genes; meta analysis; myocardial infarction; risk factors

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029738658     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.708     Document Type: Article

References (30)

1. Erdos EG. Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension. 1990;16:363-370.
2. Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakatovao R, Gonzales MF, Allegrini J, Bloch C. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am J Hum Genet. 1988;43:774-780.
3. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin I converting enzyme gene (DCPI). Nucleic Acids Res, 1992;20:1433.
4. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE. Am J Hum Genet. 1992;51:197-205.
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
6. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-643.
7. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Amouyel P, Cambien F. Deletion polymorphism in the angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993;341:991-992.
8. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet. 1993;44:292-297.
9. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet. 1993;44: 298-301.
10. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O'Rourke DF, Cambien F. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. QJM. 1994;87:211-214.
11. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994;91:3662-3665.
12. Leatham E. Barley J, Redwood S, Hussein W, Carter N, Jeffery S, Bath PMW, Camm A. Angiotensin-1 convening enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens. 1994;8:635-638.
13. Zhao Y, Higashimori K, Higaki J, Kamitani A, Ohishi M, Katsuya T, Miki T, Mikami H, Minamino T, Ogihara T. Significance of deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res. 1994;17:55-57.
14. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentrations and increased risk for coronary artery disease in the Japanese. Circulation. 1994;90:2199-2202.
15. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin convening enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis. 1995;112:137-143.
16. Mattu RK, Needham EWA, Gallon DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart study. Circulation. 1995;91:270-274.
17. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Baring J, Hennekens CH. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
18. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel J-M, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995;91:2120-2124.
19. Badenhop RF, Wang XL, Wilcken DEL. Angiotcnsin-converting enzyme genotype in children and coronary events in their grandparents. Circulation. 1995;91:1655-1658.
20. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 1995;345:1600-1603.
21. Beohar N, Damaraju S, Prather A, Yu Q-T, Raizner A, Kleiman NS, Roberts R, Marion AJ. Angiotensin-1 converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med. 1995; 43:275-280.
22. Fujisawa T, Ikegami H, Shen G-Q, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H. Rakugi H, Higaki J, Ohishi M, Fujii K, Fukuda M, Ogihura T. Angiotensin-1 converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care. 1995;18:983-985.
23. Keavney BD, Dudley CRK, Stratton IM, Holman RR, Matthews DR, Ratcliffe PJ, Turner RC. UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia. 1995;38:948-952.
24. Ahnve S, Flodin T, Berglund L, Eggertsen G, Sylven C. Angiotensin converting enzyme gene polymorphism in acute myocardial infarction patients. J Am Coll Cardiol. 1995;276A-277A. Abstract.
25. Greenlander S. Quantitative methods in the review of the epidemiological literature. Epidemiol Rev. 1987;9:1-30.
26. Dickersin K, Berlin JA. Meta-analysis: state-of-the-science. Epidemiol Rev. 1992;14:154-176.
27. Samani NJ, O'Toole L, Martin D, Rai H, Fletcher S, Lodwick D, Thompson JR, Morice AH, Channer K, Woods KL. The insertion/ deletion polymorphism in the angiotensin-converting enzyme gene and the risk of and prognosis following myocardial infarction. J Am Coll Cardiol. In press.
28. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J. 1993; 290:33-40.
29. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evand A, Arveiler D, Cambou JP, Luc G, Rakotavao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
30. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien F. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994;344:910-914.